HLA-DRB1*01:03 allele linked to severe disease requiring hospitalization, major operation, systemic corticosteroid use. HealthDay News — For patients with ulcerative colitis, the HLA-DRB1*01:03 allele ...
Fulminant colitis is a rare but severe form of colitis that can be life threatening. It affects the entire lining of the colon, causing severe inflammation and potentially serious complications. In ...
In a recent study published in the JAMA, a group of researchers identified biomarkers of severe ulcerative colitis through a Danish genome-wide association study (GWAS). Ulcerative colitis is a ...
Scientists have identified a gene that can help doctors predict which patients are likely to develop severe ulcerative colitis. The breakthrough, made by Danish researchers, means that for the first ...
VIENNA — Individuals with ulcerative colitis (UC) who carry the HLA-DRB1*01:03 allele are at increased risk of having a more severe disease course requiring major surgery, hospitalization, and ...
Everyday Health on MSN
Fulminant colitis: When an ulcerative colitis flare becomes a medical emergency
ON THIS PAGESymptomsComplicationsWhy Fulminant Colitis OccursWhat to Do During a Severe UC FlareAfter a Fulminant UC EpisodeFor some people with ulcerative colitis (UC), the symptoms are mild. But for ...
AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...
Diarrhea is a common and debilitating symptom of ulcerative colitis (UC). However, assessing the severity of diarrhea and associated fluid loss in the outpatient setting can be challenging. This ...
p #60; 0.001. Data from [74]. Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA ...
Interventional clinical trials in acute severe ulcerative colitis (ASUC) are characterized by substantial heterogeneity due to a lack of consensus in several key areas of trial design -- this impedes ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, will present five abstracts at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results